Twist Bioscience Corp (TWST) — Cash Flow-to-Debt Ratio
Twist Bioscience Corp (TWST) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2026, meaning its operating cash flow of $1.11 Million could theoretically repay 0% of its total liabilities ($226.70 Million) in one year. See TWST financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Twist Bioscience Corp Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Twist Bioscience Corp across 10 annual periods. For the full cash flow conversion analysis, see TWST cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Twist Bioscience Corp (2016–2025)
Year-by-year debt coverage analysis for Twist Bioscience Corp. Check TWST cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.28x | $-47.63 Million | $168.90 Million | ▲ +37.7% |
| 2024 | -0.45x | $-64.09 Million | $141.63 Million | ▲ +51.4% |
| 2023 | -0.93x | $-142.47 Million | $152.97 Million | ▼ -28.8% |
| 2022 | -0.72x | $-124.39 Million | $171.99 Million | ▲ +21.9% |
| 2021 | -0.93x | $-112.24 Million | $121.28 Million | ▲ +59.3% |
| 2020 | -2.27x | $-142.25 Million | $62.62 Million | ▲ +9.8% |
| 2019 | -2.52x | $-87.94 Million | $34.91 Million | ▼ -1107.6% |
| 2018 | -0.21x | $-66.16 Million | $317.21 Million | ▲ +11.0% |
| 2017 | -0.23x | $-51.30 Million | $219.01 Million | ▲ +7.1% |
| 2016 | -0.25x | $-38.59 Million | $153.07 Million | — |